Example logo GIS 26

Global Innovation Summit 2026

6 May 2026 | Basel, Switzerland

Home

Mads Holmegaard Sørensen

Co-founder

Polyceutix

Copenhagen, Denmark

18 profile visits

Co-founder of immuno-oncology and immunology startups

My organisation

Polyceutix

Polyceutix

SME

Copenhagen, Denmark

Polyceutix' lead is a first-in-class cancer immunotherapy that lets the immune system see thousands of tumor-specific proteins at once instead of a few selected targets. This has translated into strong preclinical efficacy of our ready drug candidate. We are further using our Native Nanodisc platform to generate novel targeted therapies for membrane protein related autoimmune diseases in neurology and cardiology.
Read more

About me

Current: COO/CBO & co-founder Polyceutix; CEO & co-founder Weloa care, Head of Operations Cymab

Past: Roche, Novartis, Takeda, Ferring.

Cand. Pharm, UCPH 2010

MBA, DTU/Berkeley, 2023

Social media